OPKO CEO Invests in Company

Insider purchases 40,600 shares

Author's Avatar
Jan 30, 2017
Article's Main Image

According to GuruFocus’ Insider Data, this is the largest CEO buy during the past week. The overall trend of purchases is illustrated in the chart below:

OPKO Health Inc. (OPK, Financial) CEO, Chairman and 10% owner Phillip Frost bought 44,000 shares in four separate transactions last week.

Frost bought 12,000 shares for $8.67 per share on Jan. 27; 10,000 shares for $8.55 per share on Jan. 25; 10,000 shares for $8.46 per share on Jan. 24; and 12,000 shares for $8.48 per share on Jan. 23. He made five additional stock purchases earlier in January.

OPKO is a biopharmaceutical and diagnostics company. It is engaged in the research and development of pharmaceutical products and vaccines. The company has a market cap of $4.84 billion. As of Jan. 27 its shares traded at $8.69 with a price-earnings (P/E) ratio of 36.36.

Consolidated revenues for the three months ended Sept. 30, 2016 increased to $298.0 million from $143.0 million for the comparable period in 2015. Net loss for the quarter was $15.0 million compared with net income of $128.2 million for the 2015 period.

For the complete list of stocks that bought by their company CEOs, go to: CEO Buys.

Start a free seven-day trial of Premium Membership to GuruFocus.